Literature DB >> 6252288

Requirements for DI particle prophylaxis against vesicular stomatitis virus infection in vivo.

C L Jones, J J Holland.   

Abstract

In contrast to biologically active DI particles, neither u.v.-inactivated standard virus nor either of two different homologous u.v.-inactivated DI particles showed any prophylactic effect when injected intracerebrally into mice concomitantly challenged with VSV. Although u.v.-inactivated DI particles did not prevent death when given with the challenge virus, they did significantly lengthen the time until death occurred. Also, both u.v.-inactivated standard virus and DI particles protected mice against late challenge (at 3 or 10 days after treatment). Dosage titrations of preparations of two different active DI particles showed significant prophylaxis against simultaneous challenge with numbers of DI particles 10- to 100-fold lower than those which gave no prophylaxis when u.v.-inactivated. Thus, prophylaxis in this system in this system required biologically active DI particles.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6252288     DOI: 10.1099/0022-1317-49-1-215

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

Review 1.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

2.  Conditional expression of the vesicular stomatitis virus glycoprotein gene in Escherichia coli.

Authors:  J K Rose; A Shafferman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

3.  Evidence against a requisite role for defective virus in the establishment of persistent hepadnavirus infections.

Authors:  R H Miller; R Girones; P J Cote; W E Hornbuckle; T Chestnut; B H Baldwin; B E Korba; B C Tennant; J L Gerin; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Establishment and characterisation of a porcine rubulavirus (LPMV) persistent infection in porcine kidney cells.

Authors:  B Hjertner; T Linné; J Moreno-López
Journal:  Acta Vet Scand       Date:  1997       Impact factor: 1.695

5.  Detection of vesicular stomatitis virus RNA and its defective-interfering particles in individual mouse brains.

Authors:  D R Cave; F S Hagen; E L Palma; A S Huang
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

6.  Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon.

Authors:  P N Fultz; J A Shadduck; C Y Kang; J W Streilein
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

7.  Defective interfering virus particles modulate virulence.

Authors:  D R Cave; F M Hendrickson; A S Huang
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.